Pharmaceutical Intermediates Ibandronic Acid CAS 114084-78-5 with High Purity 99%

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Diamond Member Since 2019

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

to see all verified strength labels (11)
  • Pharmaceutical Intermediates Ibandronic Acid CAS 114084-78-5 with High Purity 99%
  • Pharmaceutical Intermediates Ibandronic Acid CAS 114084-78-5 with High Purity 99%
  • Pharmaceutical Intermediates Ibandronic Acid CAS 114084-78-5 with High Purity 99%
  • Pharmaceutical Intermediates Ibandronic Acid CAS 114084-78-5 with High Purity 99%
  • Pharmaceutical Intermediates Ibandronic Acid CAS 114084-78-5 with High Purity 99%
Find Similar Products

Basic Info.

Model NO.
Ibandronic acid
Certification
GMP, HSE, ISO 9001, USP, BP
Suitable for
Elderly, Children, Adult
State
Solid
Purity
>98%
Product Name
Ibandronic Acid
CAS No.
114084-78-5
Molecular Formula
C9h23no7p2
Molecular Weight
319.23
Melting Point
113-115°c
Boiling Point
587.8±60.0 °c(Predicted)
Density
1.449±0.06 g/cm3(Predicted)
Transport Package
Foil Bag
Specification
1kg /bag
Trademark
SENWAYER
Origin
China
HS Code
32041200
Production Capacity
1000kg/Month

Product Description

Pharmaceutical Intermediates Ibandronic acid CAS 114084-78-5 with High Purity 99%
Pharmaceutical Intermediates Ibandronic Acid CAS 114084-78-5 with High Purity 99%
Product name Ibandronic acid
CAS number 114084-78-5
Molecular formula C9H23NO7P2
Molecular weight 319.23

Pharmaceutical Intermediates Ibandronic Acid CAS 114084-78-5 with High Purity 99%
Appearance White Powder
Purity 99.0%
Description Ibandronate, western medicine name. The commonly used dosage forms are injection. It is a bone regulating drug.

 

Pharmaceutical Intermediates Ibandronic Acid CAS 114084-78-5 with High Purity 99%



It is used for hypercalcemia caused by malignant tumors with or without bone metastasis, prevention and treatment of osteoporosis, prevention of bone events in breast cancer patients (pathological fractures, bone complications requiring radiation or surgical treatment) and bone metastases, as well as treatment of metastatic breast cancer.
 

Pharmaceutical Intermediates Ibandronic Acid CAS 114084-78-5 with High Purity 99%
Pharmaceutical Intermediates Ibandronic Acid CAS 114084-78-5 with High Purity 99%
Pharmaceutical Intermediates Ibandronic Acid CAS 114084-78-5 with High Purity 99%Pharmaceutical Intermediates Ibandronic Acid CAS 114084-78-5 with High Purity 99%







Pharmaceutical Intermediates Ibandronic Acid CAS 114084-78-5 with High Purity 99%Pharmaceutical Intermediates Ibandronic Acid CAS 114084-78-5 with High Purity 99%Pharmaceutical Intermediates Ibandronic Acid CAS 114084-78-5 with High Purity 99%Pharmaceutical Intermediates Ibandronic Acid CAS 114084-78-5 with High Purity 99%Pharmaceutical Intermediates Ibandronic Acid CAS 114084-78-5 with High Purity 99%

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier